News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
venBio Global Strategic Fund III, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/30/2023 |
SC 13D/A
| venBio Global Strategic Fund III, L.P. reports a 4.8% stake in Ventyx Biosciences, Inc. |
| 12/15/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/26/2022 |
SC 13D/A
| venBio Global Strategic Fund III, L.P. reports a 6.9% stake in Pharvaris N.V. |
| 09/26/2022 |
SC 13D/A
| venBio Global Strategic Fund III, L.P. reports a 8% stake in Elevation Oncology, Inc. |
| 09/26/2022 |
SC 13G/A
| venBio Global Strategic Fund III, L.P. reports a 4.9% stake in CinCor Pharma, Inc. |
| 09/14/2022 |
SC 13D/A
| venBio Global Strategic Fund III, L.P. reports a 10% stake in Ventyx Biosciences, Inc. |
| 05/27/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/11/2022 |
SC 13G
| venBio Global Strategic Fund III, L.P. reports a 5.6% stake in CinCor Pharma, Inc. |
| 11/04/2021 |
SC 13D
| venBio Global Strategic Fund III, L.P. reports a 10% stake in Ventyx Biosciences, Inc. |
| 07/09/2021 |
SC 13D
| venBio Global Strategic Fund III, L.P. reports a 11.4% stake in Elevation Oncology, Inc. |
| 02/19/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
|
|